Specific inhibition of NLRP3 with MCC950 exerts potent protective effects on NEC and NEC-induced acute brain damage as well as long-term cognitive impairment, therefore opening up a new therapeutic approach for infants suffering from NEC. Here, NLRP3 is linked to Cognitive impairment.